Header Logo

Connection

Alan Landay to Killer Cells, Natural

This is a "connection" page, showing publications Alan Landay has written about Killer Cells, Natural.
Connection Strength

2.518
  1. Modulation of TIM-3 expression on NK and T cell subsets in HIV immunological non-responders. Clin Immunol. 2015 Jan; 156(1):28-35.
    View in: PubMed
    Score: 0.462
  2. GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals. AIDS. 2013 Jul 17; 27(11):1829-32.
    View in: PubMed
    Score: 0.423
  3. Invariant NKT cells from HIV-1 or Mycobacterium tuberculosis-infected patients express an activated phenotype. Clin Immunol. 2008 Apr; 127(1):1-6.
    View in: PubMed
    Score: 0.292
  4. Natural killer cells, gamma delta T cells and classical monocytes are associated with systolic blood pressure in the multi-ethnic study of atherosclerosis (MESA). BMC Cardiovasc Disord. 2021 01 22; 21(1):45.
    View in: PubMed
    Score: 0.178
  5. Evidence of a selective depletion of a CD16+ CD56+ CD8+ natural killer cell subset during HIV infection. Cytometry. 1995 Mar 15; 22(1):10-5.
    View in: PubMed
    Score: 0.119
  6. Baseline levels of soluble CD14 and CD16+56- natural killer cells are negatively associated with response to interferon/ribavirin therapy during HCV-HIV-1 coinfection. J Infect Dis. 2012 Sep 15; 206(6):969-73.
    View in: PubMed
    Score: 0.099
  7. Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women. AIDS Res Hum Retroviruses. 2008 Feb; 24(2):163-8.
    View in: PubMed
    Score: 0.072
  8. T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor alpha, beta, or gamma genes. Immunogenetics. 1988; 27(4):231-8.
    View in: PubMed
    Score: 0.072
  9. Dysfunctional natural killer cells, in vivo, are governed by HIV viremia regardless of whether the infected individual is on antiretroviral therapy. AIDS. 2007 Nov 12; 21(17):2363-5.
    View in: PubMed
    Score: 0.071
  10. Characterization of human invariant natural killer T subsets in health and disease using a novel invariant natural killer T cell-clonotypic monoclonal antibody, 6B11. Immunology. 2007 Sep; 122(1):1-14.
    View in: PubMed
    Score: 0.070
  11. Relationship between target cell cycle and susceptibility to natural killer lysis. Cancer Res. 1987 Jun 01; 47(11):2767-70.
    View in: PubMed
    Score: 0.069
  12. Impact of class A, B and C CpG-oligodeoxynucleotides on in vitro activation of innate immune cells in human immunodeficiency virus-1 infected individuals. Immunology. 2007 Apr; 120(4):526-35.
    View in: PubMed
    Score: 0.068
  13. CD16+ NK lymphoproliferative disorders: cellular and molecular characterization. Nat Immun Cell Growth Regul. 1987; 6(3):141-9.
    View in: PubMed
    Score: 0.067
  14. Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J Immunol. 2006 Jul 15; 177(2):1028-39.
    View in: PubMed
    Score: 0.065
  15. Increased IFN-gamma production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals. Clin Immunol. 2006 Aug; 120(2):138-46.
    View in: PubMed
    Score: 0.064
  16. Siglec-9 Restrains Antibody-Dependent Natural Killer Cell Cytotoxicity against SARS-CoV-2. mBio. 2023 02 28; 14(1):e0339322.
    View in: PubMed
    Score: 0.051
  17. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection. Immunology. 2003 Jan; 108(1):3-9.
    View in: PubMed
    Score: 0.051
  18. CD56bright NK IL-7Ra expression negatively associates with HCV level, and IL-7-induced NK function is impaired during HCV and HIV infections. J Leukoc Biol. 2017 07; 102(1):171-184.
    View in: PubMed
    Score: 0.034
  19. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. PLoS One. 2012; 7(1):e30306.
    View in: PubMed
    Score: 0.024
  20. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. Clin Immunol. 2010 Apr; 135(1):12-25.
    View in: PubMed
    Score: 0.021
  21. Flow cytometric monitoring of human immunodeficiency virus-infected patients. Simultaneous enumeration of five lymphocyte subsets. Am J Clin Pathol. 1989 Dec; 92(6):721-8.
    View in: PubMed
    Score: 0.021
  22. Monocyte functional studies in asymptomatic, human immunodeficiency disease virus (HIV)-infected individuals. J Clin Immunol. 1988 Nov; 8(6):486-94.
    View in: PubMed
    Score: 0.019
  23. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP. J Immunol. 1988 Jun 15; 140(12):4271-8.
    View in: PubMed
    Score: 0.019
  24. Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells. AIDS. 2007 Jan 30; 21(3):293-305.
    View in: PubMed
    Score: 0.017
  25. Characterization of human lymphocyte subpopulations: alloreactive cytotoxic T-lymphocyte precursor and effector cells are phenotypically distinct from Leu 2+ suppressor cells. J Clin Immunol. 1984 Sep; 4(5):395-402.
    View in: PubMed
    Score: 0.014
  26. A lymphoproliferative disorder of granular lymphocytes with a novel phenotype and suppressor function. J Clin Immunol. 1984 Jul; 4(4):326-34.
    View in: PubMed
    Score: 0.014
  27. Immunologic studies in asymptomatic hemophilia patients. Relationship to acquired immune deficiency syndrome (AIDS). J Clin Invest. 1983 May; 71(5):1500-4.
    View in: PubMed
    Score: 0.013
  28. Enumeration of human lymphocyte subpopulations by immunofluorescence: a comparative study using automated flow microfluorometry and fluorescence microscopy. J Immunol Methods. 1983 Mar 25; 58(3):337-47.
    View in: PubMed
    Score: 0.013
  29. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994 Jan; 18 Suppl 1:S136-41.
    View in: PubMed
    Score: 0.007
  30. Differential surface marker expression in patients with CD-16+ lymphoproliferative disorders: in vivo model for NK differentiation. Hum Immunol. 1987 Jun; 19(2):105-15.
    View in: PubMed
    Score: 0.004
  31. Flow cytometry evaluation of cell-mediated cytotoxicity. J Immunol Methods. 1986 Nov 20; 94(1-2):247-55.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.